News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
389 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17596)
Month
January (4450)
February (4428)
March (5683)
April (4545)
May (5703)
June (4805)
July (3912)
August (4762)
September (4260)
October (3860)
November (4837)
December (2683)
Day
2 (18)
3 (192)
4 (399)
5 (344)
6 (307)
7 (143)
8 (3)
9 (40)
10 (389)
11 (192)
12 (199)
13 (188)
14 (96)
15 (3)
16 (29)
17 (74)
18 (340)
19 (185)
20 (212)
21 (85)
22 (1)
23 (15)
24 (197)
25 (192)
26 (163)
27 (186)
28 (90)
29 (1)
30 (4)
31 (163)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Business
Illumina and Boehringer Ingelheim Announce Companion Diagnostic Partnership
Illumina Inc. (NASDAQ: ILMN) today announced a partnership with Boehringer Ingelheim to develop companion diagnostics (CDx) for several programs in Boehringer Ingelheim’s oncology pipeline.
January 10, 2022
·
2 min read
Pharm Country
Quantum-Si Provides Business Updates at the 40th Annual J.P. Morgan Healthcare Conference
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” or the “Company”), a life sciences tools company commercializing a single molecule protein sequencing platform, today announced that management will discuss the following business updates at the 40th Annual J.P. Morgan Healthcare Conference.
January 10, 2022
·
5 min read
Business
Agendia Partners with Illumina to Expand Genomic Testing in Breast Cancer Care
Agendia, Inc., a commercial stage company focused on precision oncology for breast cancer, announced a multi-year partnership with Illumina, Inc., to co-develop in vitro diagnostic tests for oncology testing.
January 10, 2022
·
4 min read
Orogastric Devices Market: Increase in Incidence of Diseases among Infants to Drive the Market
Orogastric devices are small tubes placed either through the mouth and the end with the tip in the stomach, or placed through the nose as per requirement.
January 10, 2022
·
4 min read
BioCapital
QIAGEN expands QIAstat-Dx syndromic testing menu and announces launch plans for new QIAstat-Dx Rise higher-throughput version
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced important enhancements in the commercialization of its QIAstat-Dx syndromic testing solution – which enables laboratories and hospitals worldwide to test patients for multiple pathogens from one sample – with new tests and the launch of a higher-throughput version that includes a new level of walk-away efficiency through the new QIAstat-Dx Smart Drawer.
January 10, 2022
·
6 min read
Business
Annovis Bio Enhances Leadership Team with Two Senior Appointments
We are all delighted to welcome Ms. Damiano to our diverse team of highly motivated industry experts.
January 10, 2022
·
4 min read
Cardiac Monitoring & Cardiac Rhythm Management Devices Market Size to Reach USD 30.52 Billion in 2028 Growing at a CAGR of 4.1%
According to Emergen Research, the global cardiac monitoring & cardiac rhythm management devices market size was USD 22.64 billion in 2020 and is expected to reach USD 30.52 billion in 2028 and register a revenue CAGR of 4.1% during the forecast period, 2021-2028.
January 10, 2022
·
8 min read
Hematologic Malignancies Testing Market Size to Reach USD 6.24 Billion in 2028 Growing at a CAGR of 14.6%
According to Emergen Research, the global hematologic malignancies testing market size was USD 2.23 billion in 2020 and is expected to reach USD 6.24 billion in 2028 and register a revenue CAGR of 14.6% during the forecast period, 2021-2028.
January 10, 2022
·
7 min read
Telehealth Market Size to Reach USD 440.77 Billion in 2028, Says Reports and Data
Increasing prevalence of various chronic diseases and rising demand for remote patient monitoring due to high elderly population are key factors driving global market revenue growth.
January 10, 2022
·
8 min read
Animal Healthcare Industry Is Seeing Possibilities As Consumers Are Becoming More Aware Of The Benefits Of Immunization For Pets
Growth in the historic period resulted from the rapid growth in the elderly population, strong economic growth in emerging markets, decline in oil prices, and health insurance reforms globally.
January 10, 2022
·
7 min read
Previous
9 of 39
Next